Bharat Biotech published the interim efficacy report of phase 3 clinical trial on its COVID-19 vaccine, officially known as Covaxin. The indigenous COVID-19 vaccine is found to be 81 per cent effective in preventing the virus

As senior citizens across the country take part in the vaccination drive, here is all the information they need two know about the two vaccines - Covaxin and Covishield

Maharashtra reported a jump of 5,427 cases on Thursday and Mumbai reported 736 cases. Amravati has been put under a weekend lockdown and Yavatmal has been placed under restrictions

The ICMR chief said experiments are underway to assess the vaccine effectiveness against South African and Brazilian variants as they differ from the UK variant

There were no serious side effects in the participants enrolled for the phase 1 trial of Covaxin, according to the results published in The Lancet

It's great to see India's leadership in scientific innovation and vaccine manufacturing capability as the world works to end the COVID-19 pandemic, tweets the billionaire philanthropist

Comprehensive contact tracing has been initiated for co-travellers, family contacts and others.  Genome sequencing on other specimens is going on, says the government

COVID-19 vaccines in India: Oxford-AstraZeneca's coronavirus vaccine Covishield and Bharat Biotech's COVID vaccine Covaxin will be India's first vaccines

Results of the 15 samples that had tested positive for coronavirus on arrival in Ahmedabad from the UK are currently pending with the National Institute of Virology (NIV) in Pune

The new coronavirus strain has so far been detected in the US, Denmark, Netherlands, Australia, Italy, Sweden, France, Spain, Switzerland, Germany, Canada, Japan, Lebanon and Singapore

It is important from the scientific community perspective that we do not put too much immune pressure on the virus, said Bhargava

Until now, six individuals have shown traces of the new variant of coronavirus in India. All these individuals have been kept under isolation in designated health care facilities by respective state governments. Their close contacts have also been put under quarantine

All the passengers travelling from or transiting through airports in the UK and disembarking in India would be subjected to RT-PCR test on arrival

The health ministry while issuing fresh guidelines has said that passengers who travelled from or transited through the UK in the past four weeks will be required to declare their travel history of the past 14 days as well as fill up a Self-Declaration Form to be screened for COVID-19

Several experts have raised questions about Bharat Biotech applying for emergency usage as Covaxin is still going through an efficacy trial. However, the ICMR has backed Bharat Biotech's move

After American drug maker Pfizer and Pune-based Serum Institute, Bharat Biotech is the third company to apply for emergency use authorisation for its COVID-19 vaccine to the DCGI

According to the Union Health Ministry, the team comprises of Dr Jamshed Nayar, Associate Professor (Emergency Medicine), AIIMS, Dr Avinash Desohtawar, Virologist, NIV, Pune and Dr Sanket Kulkarni, Deputy Director, PH, National Centre for Disease Control

There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

A blow-by-blow account of how Indian vaccines are being readied